Form 10-K MANNKIND CORP For: Dec 31
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/12/2026
- Wall St set to gain on tech rebound, Middle East in focus
- SpaceX prices historic IPO at $135/share in largest ever new listing
- Oil drops as Trump cancels planned strikes against Iran
- Intel rallies as BofA double-upgrades stock on increased CPU, foundry visibility
- Oppenheimer sees little strategic case for Tesla-SpaceX merger
- NASDAQ adds five companies to NASDAQ-100 index in quarterly rebalance
- Adobe CFO Dan Durn to depart company in June 2026
- Oppenheimer Starts SpaceX (SPCX) at Outperform, PT $190, 'space infrastructure appears structurally advantaged'
- Pentagon reportedly locked down, hazmat teams responding
- Axsome Therapeutics (AXSM) PT Raised to $380 at Jefferies
MannKind (MNKD) PT Raised to $6.50 at Oppenheimer
February 28, 2024 8:24 AM ESTOppenheimer analyst Steven Lichtman raised the price target on MannKind (NASDAQ: MNKD) to $6.50 (from $5.50) while maintaining a Outperform rating.
The analyst comments "MNKD's 4Q23 sales of $58.5M were ahead of our/Street's $52.8M/$53.5ME. Versus our estimate, the beat was driven by... More
